Nuobikan Artificial Intelligence Technology (Chengdu) Co., Ltd. (Stock Code: 2635) entered into an investment agreement on February 12, 2026, with Bojiang Ruizhi, Bojiang Junjing, and Nuobikan Chongqing. The agreement reveals a RMB30.00 million capital injection into Nuobikan Chongqing, strengthening its research and development funding as well as product promotion capabilities.

Under the agreement, RMB15.88 million of the injected funds will be credited to the registered capital and RMB14.12 million to the capital reserve. Upon completion, the registered capital of Nuobikan Chongqing will rise from RMB90.00 million to RMB105.88 million. The shareholding structure will shift, with Nuobikan AI retaining an approximately 85% equity interest, while Bojiang Ruizhi and Bojiang Junjing will hold around 10% and 5%, respectively.

Because Nuobikan AI’s effective equity interest in Nuobikan Chongqing will decrease from 100% to approximately 85%, the deal constitutes a deemed disposal under Rule 14.29 of the Listing Rules. As Bojiang Ruizhi and Bojiang Junjing are associates of a substantial shareholder, the investment is also recognized as a connected transaction under Chapter 14A of the Listing Rules. However, since the highest applicable percentage ratio is above 0.1% but below 5%, the transaction is subject only to reporting and announcement requirements, and no independent shareholders’ approval is required.